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Estimating the Prevalence of Disease Using
Relatives of Case and Control Probands
Kristin N. Javaras, Nan M. Laird, James I. Hudson, and Brian D. Ripley
Abstract
We introduce a method for estimating the prevalence of disease using data from
a case-control family study performed to investigate the aggregation of disease in
families. The families are sampled via case and control probands, and the result-
ing data consist of information on disease status and covariates for the probands
and their relatives. We introduce estimators for overall prevalence and for covari-
ate stratum-specific prevalence (e.g., sex-specific prevalence) that yield approx-
imately unbiased estimates of their population counterparts. We also introduce
corresponding confidence intervals that have good coverage properties even for
small prevalences. The estimators and intervals address the over-representation
of diseased individuals in case-control family data by using only the relatives (of
the probands) and by taking into account whether each relative was selected via a
case or a control proband. Finally, we describe a simulation experiment in which
the estimators and intervals were applied to case-control family datasets sampled
from a fictional population that resembled the catchment area for an Austrian fam-
ily study of major depressive disorder. The resulting estimates varied closely and
symmetrically around their population counterparts, and the resulting intervals
had good coverage properties.
1. INTRODUCTION
The gold standard approach to estimating prevalence involves first obtaining a cross-sectional
(or prevalence) sample from the population of interest, then assessing whether the disease is
present in the sampled individuals, and finally calculating the proportion of sampled individuals
with the disease, sometimes with individuals weighted to reflect the probability that they were
sampled and responded. Often, researchers do not have access to an existing cross-sectional
sample that is relevant to both the population and the disease of interest, and the cost of collect-
ing one would be prohibitive. However, if they do have access to a case-control family sample
from the population of interest that was originally collected to investigate familial aggregation
of the disease, it can be used to obtain valid estimates of prevalence, as we show below.
Case-control family studies are conducted to investigate the extent to which a disease aggre-
gates (with itself) within families, or co-aggregates with other diseases within families (Hudson
et al., 2001). In these studies, researchers select case probands who are affected by the disease
and control probands who are not, and then select relatives from among the case and control
probands’ family members (e.g., first-degree relatives). The resulting data consist of informa-
tion on disease status and covariates for the case and control probands and their relatives. When
the data is used to investigate familial aggregation, the most basic analysis entails comparing
the proportion of affected relatives for case probands to the proportion of affected relatives for
control probands. Here, we refer to an example that is a case-control family study of major
depressive disorder (MDD) conducted at Innsbruck University Clinics in Innsbruck, Austria
(Hudson et al., 2003). In the study, 64 adults with MDD (case probands) were selected from the
psychiatric unit, and 58 adults without MDD (control probands) were selected from the surgical
and ophthalmology units. Three hundred and thirty of the probands’ adult first-degree relatives
(parents, siblings, children) consented to participate in the study. Table 1 presents the numbers
of relatives with and without MDD, by proband disease status and relative sex.
The probands provide no information on prevalence because the proportion of affected (or
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case) probands is fixed by design. The relatives, on the other hand, do provide information on
prevalence, but the simple proportion of affected relatives is a biased estimate of prevalence if
the disease aggregates in families because, in that case, the relatives’ probability of selection
depends on their disease status, albeit indirectly (through the probands’ disease statuses). How-
ever, by using only the relatives and conditioning on the disease status of the probands through
which the relatives were selected, we can obtain valid estimates and confidence intervals for
overall and stratum-specific (e.g., sex-specific) prevalence, provided that certain commonly-
made assumptions about sampling and the population structure hold. Our method yields es-
timates that are biased only slightly downwards for their population counterparts. Further,
they are less seriously biased than estimates from other commonly-used methods of estimating
prevalence from case-control family data, such as the proband or propositus method (Kendler
and Eaton, 1988; Stro¨mgren, 1948). Our method performs very well when applied to datasets
sampled from a fictional population: the resulting estimates vary closely and symmetrically
around their population counterparts, with only a very small downwards bias, and the resulting
intervals have good coverage properties.
The paper is organized as follows. Section 2 introduces our estimators for overall preva-
lence and stratum-specific prevalence, as well as the assumptions on which they rely. Section
3 presents the results of the simulation experiment, and Section 4 is a discussion of the advan-
tages and limitations of the method. Appendices A and B contain proofs that the overall and
stratum-specific estimators, respectively, are approximately unbiased for their population coun-
terparts. Finally, Appendix C introduces standard errors and confidence intervals for overall
and stratum-specific prevalence.
2. ESTIMATION
Before presenting estimators for overall and stratum-specific prevalence, it is necessary to in-
troduce some notation, as well as several assumptions. These assumptions are commonly, if
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implicitly, made when analyzing data from case-control family studies; here, they are used to
guarantee that the proposed estimators will be approximately unbiased. The assumptions de-
scribe a simplified model for the underlying population and for the ascertainment of case-control
families from it. Although not a perfect representation of reality, this simplified model is an ad-
equate approximation to reality when the size of the population is sufficiently large (relative to
the sizes of the families that comprise the population and relative to the number of probands
ascertained in the study). Further, the results of the simulation experiment in Section 3 suggest
that our method is robust to violations of the assumptions underlying the simplified model.
We will assume that the population of interest is finite (but very large) and that it can be
partitioned into F mutually exclusive and exhaustive families of siblings. These families are
indexed by i. Family i has Ni members, who are indexed by ij, where j = 1, . . . , Ni. For
individual ij, we use Yij to denote disease status, with 1 corresponding to presence of the dis-
ease and 0 corresponding to absence of the disease. The population prevalence, pi, is defined
as f(Yij = 1), where individual ij is randomly selected from the population. Similarly, the
stratum-specific prevalence, pix, is defined as f(Yij = 1|Xij = x), where Xij is a categorical
variable whose levels define covariate strata of interest (e.g., males and females); x is a par-
ticular value of Xij (e.g., the female stratum); and individual ij is randomly selected from the
population in stratum x. Note that Xij may result from coarsening the values of a continuous
variable (e.g., age) or from crossing the levels of multiple categorical variables (e.g., sex and
race).
Families are ascertained for the case-control family study via F
A
unrelated probands with
the disease and F
U
unrelated probands without the disease. Once families have been ascer-
tained, they are renumbered, as are their members. The re-numbered families are now indexed
by i˜, where, for the sake of convenience, the values i˜= 1, . . . , FA refer to families ascertained
via case probands, the values i˜= FA +1, . . . , FA +FU refer to families ascertained via control
probands, and the values i˜ = FA + FU , . . . , F refer to unascertained families. For ascertained
3
Hosted by The Berkeley Electronic Press
family i˜, disease status and covariate information is obtained for only ni˜− 1 of the Ni˜− 1 re-
maining (i.e., non-proband) family members. The re-numbered members of ascertained family
i˜ are now indexed by i˜j˜, where j˜ = 1 refers to the proband, j˜ = 2, . . . , ni˜ refer to the sampled
relatives, and j˜ = ni˜+ 1, . . . , ni˜+ Ni˜ refer to the unsampled relatives. The original index j,
which refers to an individual as a member of a family in the population, has a 1:1 mapping to
the index j˜, which refers to the individual as a member of his or her family once it has been
ascertained. We use ri(j) to refer to the renumbered index for the jth member of the ith family
in the population once his or her family has been ascertained.
Below, we show how data from a case-control family study can be used to obtain estimates
of overall prevalence and stratum-specific prevalence. Several more assumptions must hold for
the proposed estimators to yield approximately unbiased estimates:
(i.) Availability of Relatives: Each member of the population of interest has at least one living
relative.
(ii.) Family Size and Disease Status are Uncorrelated: Cor(Ni, N
A
i
Ni
) = 0, where NAi =∑Ni
j=1 I(Yij = 1), the number of affected members in family i.
(iii.) Proband Sampling: The case probands are randomly sampled from the affected members
of the population, and the control probands are randomly sampled from the unaffected
members of the population.
(iv.) Single Ascertainment: The number of case (control) probands is sufficiently small relative
to the number of affected (unaffected) members of the population to guarantee that no
family will be selected via more than one proband.
(v.) Relative Sampling: Given that family i has been ascertained, the probability that indi-
vidual i˜j˜ (j˜ 6= 1) is included in the study is a constant (referred to as s) and, thus, does
not depend on Yi˜j˜ (his or her disease status), Xi˜j˜ (his or her covariates), Yi˜(−j˜) (the dis-
ease statuses for the other members of the family), Xi˜(−j˜) (the covariates for the other
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members of the family), or on Ni˜ (the family’s size).
(vi.) Disease Status is Independent of Other Family Members’ Covariates: For individual ij,
Yij (his or her disease status) is independent of Xi(−j) (the covariates for the other mem-
bers of the family), conditional on Xij (the individual’s covariate)
If Assumptions (i.)-(v.) hold, then the following estimator is approximately unbiased at the
first-order for the overall prevalence of disease in the population (see Appendix A for a proof):
pˆi =
p
U
1− p
A
+ p
U
, (2.1)
where p
A
is the proportion of case probands’ relatives who are affected,
p
A
=
F
A∑
i˜=1
ni∑˜
j˜=2
I(Yi˜j˜= 1)
F
A∑
i˜=1
ni∑˜
j˜=2
1
;
and p
U
is the proportion of control probands’ relatives who are affected,
p
U
=
F
A
+F
U∑
i˜=FA+1
ni∑˜
j˜=2
I(Yi˜j˜= 1)
F
A
+F
U∑
i˜=FA+1
ni∑˜
i˜=2
1
.
Further, we can show that the slight bias introduced by the second-order terms is downward
when F
A
≈ F
U
(the number of case probands is approximately equal to the number of control
probands) and when E(1 − p
U
) > E(p
A
) (the expected proportion of control probands’ rela-
tives who are unaffected is greater than the expected proportion of case probands’ relatives who
are affected).
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Note that the estimator in (2.1) adjusts p
U
, an estimate of prevalence based on relatives of
control probands only, by the factor 11−p
A
+p
U
. Since E(p
A
) > E(p
U
) for diseases that aggre-
gate in families, this adjustment will usually have the effect of moving the prevalence estimate
upwards from p
U
. Thus, using p
U
to estimate overall prevalence—an approach that is referred
to as the proband or propositus method and has been widely used in genetic-epidemiologic
studies of psychiatric disorders (Kendler and Eaton, 1988; Stro¨mgren, 1948)—results in greater
downward bias than using the estimator in (2.1), except when the disease does not aggregate
in families. Similar arguments reveal that p
A
overestimates prevalence except when the disease
does not aggregate in families.
Next, if Assumptions (i.)-(vi.) hold, then the following estimator is biased only slightly at
the first-order for the prevalence of disease in stratum x (see Appendix B for a proof):
pˆix = px
A
pˆi + px
U
(1− pˆi), (2.2)
where px
A
is the proportion of case probands’ relatives who have covariate value x and are
affected
px
A
=
F
A∑
i˜=1
ni∑˜
j=2
I(Xi˜j˜= x)I(Yi˜j˜= 1)
F
A∑
i˜=1
ni∑˜
j˜=2
I(Xi˜j˜= x)
;
and px
U
is the proportion of control probands’ relatives who have covariate value x and are
affected
px
U
=
F
A
+F
U∑
i˜=FA+1
ni∑˜
j˜=2
I(Xi˜j˜= x)I(Yi˜j˜= 1)
F
A
+F
U∑
i˜=FA+1
ni∑˜
j˜=2
I(Xi˜j˜= x)
.
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Further, we can show that the slight first-order bias is downwards when, again, F
A
≈ F
U
and
E(1 − p
U
) > E(p
A
). Note that, as above, an examination of Equation (2.2) reveals that using
only the relatives of control probands to estimate stratum-specific prevalence results in more
serious underestimation than using the estimator in (2.2), except when the disease does not ag-
gregate in families.
In Appendix C, we provide approximate standard errors and confidence intervals for pˆi and
pˆix. The standard errors and confidence intervals are appropriate for dependent observations
since disease status will be positively correlated within families when the disease aggregates in
families. The confidence intervals are based on the same concept as the Agresti-Coull (1998)
interval, which modifies the standard Wald interval for binomial proportions so that it will at-
tain actual coverage levels near the nominal coverage level even for small proportions. The
modification, which has strong roots in the work of Wilson (1927), involves replacing the max-
imum likelihood estimate of the proportion used to calculate the center and standard error of
the Wald interval with an estimate that is smoothed towards the uniform probability distribution
by adding a small number (e.g., two) of successes and the same number of failures to the ob-
served data. Because the Agresti-Coull interval appears to perform well for small independent
samples (1998) and, more relevantly for our data, medium-sized dependent samples (Miao and
Gastwirth, 2004), we use a similar approach to form confidence intervals: the intervals’ center
and spread are calculated using p˜
A
, p˜
U
, p˜x
A
, and p˜x
U
, which smooth p
A
, p
U
, px
A
, and px
U
, respec-
tively, towards the uniform distribution by adding two failures and two successes for every 100
observations.
To illustrate the use of our method, we apply it to the data from the Austrian case-control
family study. Equations (2.1) and (C.3) yield an estimate of 8.8% and a 95% confidence in-
terval of [5.9%, 15%], respectively, for the overall lifetime prevalence of MDD in the Tyrol
region. Equations (2.2) and (C.4) yield an estimate of 6.0% and a 95% confidence interval of
[2.3%, 13%] for male lifetime prevalence, and 11.3% and [6.4%, 20.0%] for female lifetime
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prevalence. Note that the overall, male, and female prevalence estimates are larger than the
affected proportions of all relatives, male relatives, and female relatives of control probands
(7.9%, 5.5%, and 10.1%, respectively), but considerably smaller than the affected proportions
of all relatives, male relatives, and female relatives of case probands (18.5%, 11.0%, and 23.8%,
respectively).
3. RESULTS OF THE SIMULATION EXPERIMENT
We conducted a simulation experiment to investigate how well the estimators from Section 2
and the confidence intervals from Appendix C perform in practice. The experiment was de-
signed to mimic the Austrian case-control family study of MDD, which is at the smaller end of
case-control family studies.
We created a fictional population with approximately 500, 000 individuals, which corre-
sponds to the number of people between 18 and 70 years old reported to be living in the Tyrol
region of Austria, the catchment area for the Austrian study, in 2003 (Statistik Austria, 2003).
To create a population of this size, we generated data for approximately 125, 000 families, which
involved three steps: (a) generating family sizes based on the distribution of family sizes in the
Austrian data; (b) generating the sexes of and relationships between (e.g., siblings, parents, etc.)
family members based on the percentage of females between 18 and 70 years in the Tyrolean
population in 2003 (=50.5%) and the distribution of family relationships and sex in the Austrian
data, and; (c) generating lifetime disease statuses for the family members conditional on their
sexes and relationships, based on parameter estimates from the Austrian data.
To generate the disease statuses in step (d), we used the ACE (A = additive genetic effects, C
= common or shared family environment, and E = unique environment) model for case-control
family data (Javaras et al., 2007). In this model, a subject is affected if his or her ‘liability to the
disease’ exceeds a threshold that corresponds to disease prevalence for the relevant covariate
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stratum. The liabilities for subjects from family i are modeled by an Ni-variate normal distri-
bution with mean vector set to zero and correlations that are a function of a2 (the percentage
of variation in liability due to A) and c2 (the percentage of variation in liability due to C). In
our experiments, we set the ACE model’s parameters to values based on analysis of the actual
MDD data (Javaras et al., 2007, Section 6): we set a2 to 0.45, c2 to 0, lifetime disease preva-
lence among males to 6.0%, and lifetime disease prevalence among females to 11.3%. Note that
the male and female prevalences, along with the proportion of females, determine the overall
lifetime prevalence of disease (= 8.8%) for the fictional population.
Next, we sampled 1, 000 small case-control family datasets from the fictional population.
Each dataset was formed by selecting F
A
= 64 case probands and F
U
= 58 control probands,
and then including all of the probands’ family members (s = 1). (F
A
, F
U
, and s were set
equal to their values in the Austrian study.) For each sampled dataset, Equation (2.1) was used
to estimate overall prevalence, and Equation (2.2) was used to estimate the male and female
prevalences. In addition, we used Equation (C.3) to form two-sided and lower and upper one-
sided 95% confidence intervals for the overall prevalence, and we used Equation (C.4) to form
the same confidence intervals for the male and female prevalences.
In the 1, 000 case-control family datasets sampled, the number of included individuals (rel-
atives plus probands) ranged between 449 and 541. Even for this relatively small study size,
the population was not sufficiently large to ensure single ascertainment: in 122 of the 1, 000
datasets, at least one family was doubly ascertained. In these instances, the first family member
to be selected as a proband was retained as the sole proband for his or her family. Figure 1
presents boxplots of the resulting prevalence estimates for the 1, 000 datasets. The plots reveal
that the prevalence estimates vary symmetrically and closely around the population prevalences,
which are indicated by “X”s. The downward bias in the estimates is extremely small (especially
relative to the length of the confidence intervals): the means of the 1, 000 estimates are within
−0.0008 (−0.9%), −0.0006 (−0.5%), and −0.0011 (−1.9%) of the overall, male, and female
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prevalences, respectively. The two-sided 95% confidence intervals for overall, male, and female
prevalence have mean lengths 0.105, 0.146, and 0.114, respectively. Although these intervals
are fairly wide, especially for such small estimates, this is to be expected due to the positive
correlation of MDD status within families. The actual coverage probabilities of the intervals for
overall, male, and female prevalence are 94.9%, 90.5%, and 98.8% for the two-sided 95% con-
fidence intervals, 96.2%, 94.4%, and 97.2% for the one-sided lower 95% confidence intervals,
and 94.7%, 93.1%, and 96.8% for the one-sided upper 95% confidence intervals. Note that the
two-sided intervals, which will be used most often in practice, attain actual coverage levels very
close to the nominal level of 95%. Note also that the actual coverage levels are generally a little
too high for the upper one-sided intervals and generally a little too low for the lower one-sided
intervals. This phenomenon reflects the fact that the intervals are calculated using estimated
proportions that are smoothed away from zero.
The simulation experiment suggests that the prevalence estimators in (2.1) and (2.2) are
approximately unbiased and reasonably efficient, even when the population size is relatively
small and the assumption of single ascertainment does not hold. As would be expected, our
estimators and confidence intervals perform even better in additional similar experiments (not
described here) that involve a larger fictional population with over 2 million individuals.
4. DISCUSSION
We have introduced a method of forming estimates and confidence intervals for overall and
stratum-specific prevalence based on case-control family data.
It is clear from the simulation experiment (Section 3) and proofs (Appendices A and B) that
the proposed estimators and intervals yield valid information about the prevalence of disease.
The ability to glean valid information about disease prevalence from case-control family data
is useful to medical researchers when no population-based data (from a cross-sectional sample)
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are available for the population of interest. Knowledge of prevalence augments epidemiologi-
cal understanding of the disease and also informs resource allocation. In addition, knowledge
of prevalence makes it possible to estimate other parameters of epidemiological interest. For
instance, data from a case-control sample can be weighted to create data representative of the
population by using weights equal to the inverse sampling probabilities for the cases and con-
trols, the calculation of which requires knowledge of prevalence. The weighted data that result
can be used to obtain approximately unbiased estimates of population parameters, such as the
exposure-disease risk difference and the exposure-disease risk ratio, that cannot be obtained
from case-control studies unless the sampling fractions of cases and controls is known. (In con-
trast, the exposure-disease odds ratio can, of course, be obtained from case-control data without
weighting them.)
Several limitations should be noted. For one, when the disease of interest aggregates in
families, disease status will be positively correlated for individuals within the same family,
which will have the effect of inflating the errors and intervals for pˆi and pˆix. Thus, in this case,
the prevalence estimators in Equations (2.1) and (2.2) will be less precise than corresponding
estimators based on the same number of unrelated individuals from a cross-sectional sample.
Further, the estimates and intervals would probably not perform well for very small proportions
unless the sample size were very large, but this would also be true for estimates and intervals
calculated from cross-sectional samples.
Second, the prevalence estimators may no longer be unbiased if one or more of the assump-
tions enumerated in Section 2 are violated. For example, if smaller families have a greater
proportion of affected individuals, a violation of Assumption (ii.), then prevalence may be un-
derestimated (Kendler and Eaton, 1988). This scenario is plausible for early-onset diseases that
impair individuals’ ability to have children or for diseases that result in early death. However,
results from the simulation experiment suggest that violations of Assumption (ii.) introduce
only a very small amount of bias, as shown in the right-hand columns of Tables 2 and 3 in
11
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the appendices. As another example, if probands are selected based not only on their disease
status but also on disease characteristics such as severity, a violation of Assumption (iii.), then
the resulting prevalence estimates may be biased. This is a potential problem for the Aus-
trian study because the case probands were sampled from a psychiatric clinic rather than from
the community. In contrast, if probands are selected based not only on disease status but also
on measured covariates such as sex or age, another violation of Assumption (iii.), estimates of
stratum-specific prevalence can still be obtained by applying Equation (2.2) only to the relatives
of those probands who belong to the stratum of interest. As for violations of Assumption (iv.),
the simulation experiment in Section 3 suggests that our method is robust to at least moderate
departures from single ascertainment. Next, if the affected relatives of the probands are less
likely to participate in the study, a violation of Assumption (v.), then prevalence will be under-
estimated. Finally, if the disease of interest is extremely common or if it is somewhat common
and aggregates extensively in families, then it may not be true that E(1 − p
U
) > E(p
A
). It
is easy to see why this inequality will not hold if the disease in question is extremely common
(prevalence over 50%), since in that case E(p
A
) will be large and E(1−p
U
) will be small even
if the disease does not aggregate in families. Another case where the inequality will not hold is
when the disease aggregates in families to such an extent that Ep
A
is large and when the dis-
ease is common enough so that E(1 − p
U
) is not large. However, for most diseases (including
MDD), the inequality will hold. Further, since the assumption that E(1 − p
U
) > E(p
A
) is
required only to ensure that the bias in pˆi is downwards, our method will still be approximately
unbiased even when this assumption is violated.
In general, though, our method appears to be reasonably robust to the violation of most
assumptions. The most crucial assumption is likely to be the one about relative sampling, which
assumes that individuals with the disease are no more or less likely to be included in the sample
than individuals without the disease. This assumption would apply equally to cross-sectional
samples. The second-most crucial assumption is likely to be the assumption that family size and
disease status are uncorrelated in the population of interest. If these two crucial assumptions
12
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hold, then our method of estimating disease prevalence from case-control family data is a useful
tool, especially for diseases and populations where no cross-sectional samples are available.
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APPENDIX A
Proof that pˆi is approximately unbiased at the first-order for pi
The overall population prevalence is defined as pi ≡ f(Yij = 1), where individual ij is ran-
domly selected from the population of interest. Assumption (i.) about the availability of rela-
tives allows us to expand f(Yij = 1) as follows
pi ≡ f(Yij = 1)
= f(Yij = 1|Yij′ = 1)f(Yij′ = 1) + f(Yij = 1|Yij′ = 0)f(Yij′ = 0), (A.1)
where individual ij′ is randomly selected from among Yij’s relatives with disease status Yij′.
(In the remainder of this proof, we will assume that j′ 6= j.) We can rewrite the above equation
as
pi = f(Yij = 1|Yij′ = 1)pi + f(Yij = 1|Yij′ = 0)(1 − pi),
which can be rearranged to give
pi =
pi
U
1− pi
A
+ pi
U
, (A.2)
where pi
U
≡ f(Yij = 1|Yij′ = 0) and piA ≡ f(Yij = 1|Yij′ = 1). The parameters piA and piU
can be defined in terms of the finite population:
pi
A
≡ f(Yij = 1|Yij′ = 1)
=
∑F
i=1
∑Ni
j=1
∑
j′ 6=j I(Yij = 1) I(Yij′ = 1)∑F
i=1
∑Ni
j=1
∑
j′ 6=j I(Yij′ = 1)
=
∑F
i=1
∑Ni
j=1 I(Yij = 1)(NAi − 1)∑F
i=1
∑Ni
j=1
(
I(Yij = 0)NAi + I(Yij = 1)(NAi − 1)
)
=
∑F
i=1(N
A
i − 1)NAi∑F
i=1(Ni − 1)NAi
; (A.3)
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where NAi =
∑Ni
j=1 I(Yij = 1), the number of affected members in family i, and
pi
U
≡ f(Yij = 1|Yij′ = 0)
=
∑F
i=1
∑Ni
j=1
∑
j′ 6=j I(Yij = 1) I(Yij′ = 0)∑F
i=1
∑Ni
j=1
∑
j′ 6=j I(Yij′ = 0)
=
∑F
i=1
∑Ni
j=1 I(Yij = 1)NUi∑F
i=1
∑Ni
j=1
(
I(Yij = 0)(NUi − 1) + I(Yij = 1)NUi
)
=
∑F
i=1 N
A
i N
U
i∑F
i=1(Ni − 1)NUi
, (A.4)
where NUi =
∑Ni
j=1 I(Yij = 0), the number of unaffected members in family i.
Now, recall that
pˆi =
p
U
1− p
A
+ p
U
, (A.5)
where p
A
is the proportion of case probands’ relatives who are affected,
p
A
=
F
A∑
i˜=1
ni∑˜
j˜=2
I(Yi˜j˜= 1)
F
A∑
i˜=1
ni∑˜
j˜=2
1
;
and p
U
is the proportion of control probands’ relatives who are affected,
p
U
=
F
A
+F
U∑
i˜=FA+1
ni∑˜
j˜=2
I(Yi˜j˜= 1)
F
A
+F
U∑
i˜=FA+1
ni∑˜
j˜=2
1
.
The estimator pˆi in (A.5) can be approximated by a second-order Taylor expansion around
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Ep
U
and Ep
A
, the expected values of p
U
and p
A
, respectively:
pˆi ≈ EpU
1− Ep
A
+ Ep
U
+ (p
U
− Ep
U
)
∂pˆi
∂p
U
∣∣∣∣
Ep
U
,Ep
A
+ (p
A
− Ep
A
)
∂pˆi
∂p
A
∣∣∣∣
Ep
U
,Ep
A
+
1
2
(p
U
− Ep
U
)2
∂2pˆi
∂p
U
2
∣∣∣∣
Ep
U
,Ep
A
+
1
2
(p
A
− Ep
A
)2
∂2pˆi
∂p
A
2
∣∣∣∣
Ep
U
,Ep
A
+(p
U
− Ep
U
) (p
A
− Ep
A
)
∂2pˆi
∂p
U
∂p
A
∣∣∣∣
Ep
U
,Ep
A
Inserting expressions for the derivatives and then taking the expectation of both sides of the
above equation yields
Epˆi ≈ EpU
1− Ep
A
+ Ep
U
− Var(pU ) (1− EpA)
(1− Ep
A
+ Ep
U
)3
+
Var(p
A
)Ep
U
(1− Ep
A
+ Ep
U
)3
(A.6)
+
Cov(p
U
, p
A
) (1− Ep
A
− Ep
U
)
(1− Ep
A
+ Ep
U
)3
In order to determine the bias in the leading term on the right-hand side of (A.6), we must
derive expressions for the bias of p
A
and p
U
as estimators for pi
A
and pi
U
, respectively. Be-
ginning with the former, we introduce indicators in order to rewrite p
A
as a sum over every
member of every family in the population, except for one affected member of each family who
is arbitrarily designated as the (case) proband:
p
A
=
F∑
i=1
∑
{j: j∈J˜i}
δAij I(Yij = 1)
F∑
i=1
∑
{j: j∈J˜i}
δAij
where J˜i = {j : 1 ≤ j ≤ Ni and ri(j) 6= 1}, a set containing the indices of the non-proband
members of family i (after ascertainment); and δAij equals 1 if family member ij is sampled as
part of a case-ascertained family and equals 0 otherwise. The indicator δAij will depend on δAi ,
the case-ascertainment indicator for family i, which equals 1 if family i is ascertained via an
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affected proband and 0 otherwise (with the constraint that ∑Fi=1 δAi = FA .) If δAi = 0, then
δAij = 0 by definition, but if δAi = 1, then δAij can equal 0 or 1.
To obtain an expression for the bias of p
A
as an estimator for pi
A
, we employ the strategy of
Hartley and Ross (1954) for determining the bias of a ratio estimator. This strategy begins by
expanding the covariance between p
A
and its denominator:
Cov
(
p
A
,
F∑
i=1
∑
{j: j∈J˜i}
δAij
)
= E
( F∑
i=1
∑
{j: j∈J˜i}
δAijI(Yij = 1)
)
− Ep
A
· E
( F∑
i=1
∑
{j: j∈J˜i}
δAij
)
=
F∑
i=1
∑
{j: j∈J˜i}
E(δAij)I(Yij = 1)− EpA ·
F∑
i=1
∑
{j: j∈J˜i}
E(δAij)
=
F∑
i=1
∑
{j: j∈J˜i}
E
(
E
(
δAij |δAi
))
I(Yij = 1)− EpA ·
F∑
i=1
∑
{j: j∈J˜i}
E
(
E
(
δAij |δAi
))
.
Under Assumption (v.), the probability that relative ij is sampled is a constant referred to as s.
Using this fact to replace E
(
δAij |δAi
)
in the last line of the above equation yields
Cov
(
p
A
,
F∑
i=1
∑
{j: j∈J˜i}
δAij
)
=
F∑
i=1
∑
{j: j∈J˜i}
E
(
sδAi + 0(1− δAi )
)
I(Yij = 1)
− Ep
A
·
F∑
i=1
∑
{j: j∈J˜i}
E
(
sδAi + 0(1 − δAi )
)
= s
F∑
i=1
E(δAi )
∑
{j: j∈J˜i}
I(Yij = 1)− EpA · s
F∑
i=1
E(δAi )
∑
{j: j∈J˜i}
1
= s
F∑
i=1
E(δAi )(NAi − 1)− EpA · s
F∑
i=1
E(δAi )(Ni − 1)
= sF
A
s
A
F∑
i=1
NAi (N
A
i − 1)− EpA · sFA sA
F∑
i=1
NAi (Ni − 1)
where the third line follows because J˜i does not include one affected member of family i who
is designated as the case proband; and where the fourth line follows because, under Assumption
17
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(iii.) about proband selection and Assumption (iv.) about single ascertainment, E(δAi ) can be
rewritten as NAi FA sA , where sA = 1/
∑F
i=1 N
A
i , the sampling fraction for case probands. The
last line above can be rearranged to give
Ep
A
−
F∑
i=1
NAi (N
A
i − 1)
F∑
i=1
NAi (Ni − 1)
= −
Cov
(
p
A
,
F∑
i=1
∑
{j: j∈J˜i}
δAij
)
sF
A
s
A
F∑
i=1
NAi (Ni − 1)
.
Since the second term on the lefthand side of the above equation is just pi
A
as written in (A.3),
the bias of p
A
can be written as
Ep
A
− pi
A
= −
Cor
(
p
A
,
F∑
i=1
∑
{j: j∈J˜i}
δAij
)
· SD(p
A
) · SD( F∑
i=1
∑
{j: j∈J˜i}
δAij
)
sF
A
s
A
F∑
i=1
NAi (Ni − 1)
. (A.7)
Since the denominator on the righthand side of the above equation equals the expectation of∑F
i=1
∑
{j: j∈J˜i} δAij , we can rewrite (A.7) as
Ep
A
− pi
A
= − Cor
(
p
A
,
F∑
i=1
∑
{j: j∈J˜i}
δAij
)
· SD(p
A
) · CV( F∑
i=1
∑
{j: j∈J˜i}
δAij
)
, (A.8)
where CV(
∑F
i=1
∑
{j: j∈J˜i} δAij), the coefficient of variation, is defined as the ratio of the stan-
dard deviation of
∑F
i=1
∑
{j: j∈J˜i} δAij to the mean of
∑F
i=1
∑
{j: j∈J˜i} δAij .
We examine the magnitude of each of the three multiplicands on the righthand side of (A.8).
First, SD(p
A
) must be less than 0.5 because p
A
is a proportion. Second, it is difficult (if not im-
possible) to construct a population where CV
(∑F
i=1
∑
{j: j∈J˜i} δAij
)
is larger than 2, as would
be expected for a quantity that is effectively the sum of binary variables (albeit non-identical,
18
http://biostats.bepress.com/cobra/art31
non-independent ones). Third, under Assumption (ii.), which states that family size and dis-
ease status are uncorrelated, Cor
(
p
A
,
∑F
i=1
∑
{j: j∈J˜i} δAij
)
is negligible. This is true because
Assumption (ii.) ensures that the average size of the case-ascertained families included in the
study will have a negligible correlation with the proportion of the relatives in those families
who have the disease. Putting these three facts together, we see that the bias of p
A
is negligible
when Assumption (ii.) holds.
To illustrate the importance of Assumption (ii.) in guaranteeing that p
A
is approximately
unbiased for pi
A
, we examine the bias of p
A
in two fictional populations. The first is the same
population used in the simulation experiment in Section 3. The second is a population created in
an identical fashion, except that the prevalence of disease was set lower for males and females
from families with more than three members and set higher for males and females from fami-
lies with fewer than three members. Note that the overall prevalence of disease is equal in both
populations, but in the second population, a disproportionately large number of the diseased
individuals belong to small families. For each population, we sampled 1, 000 datasets, each
consisting of 64 case probands (F
A
= 64) and all of their relatives (s = 1). We calculated p
A
and
∑F
i=1
∑
{j: j∈J˜i} δAij for each dataset and then used the resulting values to estimate the three
multiplicands in (A.8) for that population. Table 2 presents the values of the three multiplicands
in the two populations, as well as the bias of p
A
in percentage terms. The middle column of
Table 2 reveals that Cor
(
p
A
,
∑F
i=1
∑
{j: j∈J˜i} δAij
)
and the percentage bias of p
A
are negligi-
ble in the first population, where Assumption (ii.) holds. Comparing the middle column to the
right-most column in Table 2 reveals that the percentage bias of p
A
is approximately 100 times
larger for the second population, where Assumption (ii.) does not hold. This increase in bias is
due to the larger value of Cor
(
p
A
,
∑F
i=1
∑
{j: j∈J˜i} δAij
)
.
We can use the approach employed above to obtain an analogous expression for the bias of
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p
U
as an estimator for pi
U
Ep
U
− pi
U
= − Cor
(
p
U
,
F∑
i=1
∑
{j: j∈J˜i}
δUij
)
· SD(p
U
) · CV( F∑
i=1
∑
{j: j∈J˜i}
δUij) (A.9)
where δUij equals 1 if relative ij is sampled as part of a control-ascertained family and equals
0 otherwise. Since the same arguments made for the multiplicands in (A.8) also apply to the
multiplicands in (A.9), we see that the bias of p
U
will be negligible when Assumption (ii.)
holds. For both populations described above, Table 3 presents values of the three multiplicands
in (A.9) and the percentage bias of p
U
, calculated from 1, 000 datasets containing F
U
= 58
control probands and all of their relatives (s = 1). The bias of p
U
is negligible for the first
population, but is again approximately 100 times larger for the second population because the
correlation between p
U
and its denominator is larger. Thus, the bias of p
U
is negligible when
Assumption (ii.) holds.
The fact that p
A
and p
U
have negligible bias under the assumptions enumerated in Section
2 implies that the bias in the leading term of (A.6) is negligible. Thus, to a first-degree approx-
imation, pˆi is an unbiased estimator for pi.
We now turn to the bias introduced by the second-order terms in (A.6). First, note that
the final second-order term in (A.6) introduces no bias because Cov(p
A
, p
U
) = 0. Next,
note that the numerators of the first two second-order terms in (A.6) can be re-written as[
Ep
U
(1− Ep
U
)/
∑F
A
+F
U
i˜=FA+1 (ni˜− 1)
]
(1−Ep
A
) and
[
Ep
A
(1− Ep
A
)/
∑F
A
i˜=1 (ni˜− 1)
]
Ep
U
,
respectively. We can ignore the summations in the denominators of these terms because they
are approximately equal under assumption (ii.) that disease status is uncorrelated with family
size and under the assumption that F
A
≈ F
U
. Now, the only difference between the two terms
is that (1 − Ep
A
)Ep
U
is multiplied by (1 − Ep
U
) in the first term and by Ep
A
in the second
term. Thus, if we assume that E (1− p
U
) > Ep
A
, then the first second-order term, which has
a negative sign in front of it, is larger in magnitude than the second second-order term, which
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has a positive sign in front of it. As a result, the bias introduced through the second-order terms
in (A.6) will be non-positive if E (1− p
U
) > Ep
A
and F
A
≈ F
U
. However, the results of the
simulation experiment in Section 3, where pˆi underestimates pi by only a very small amount,
suggest that the bias introduced through the second- (and higher-) order terms is very small in
practice. 
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APPENDIX B
Proof that pˆix is only slightly biased at the first-order for pix
We define pix ≡ f(Yij = 1|Xij = x), where individual ij is randomly selected from among
the members of the population with Xij = x. Assumption (i.) allows us to expand f(Yij =
1|Xij = x) as
pix = f(Yij = 1|Yij′ = 1,Xij = x)f(Yij′ = 1|Xij = x) (B.1)
+ f(Yij = 1|Yij′ = 0,Xij = x)f(Yij′ = 0|Xij = x),
where individual ij′ is randomly selected from among Yij’s relatives with disease status Yij′.
(In the remainder of this proof, we will assume that j′ 6= j.) Under Assumption (vii.) about the
independence of probands’ disease status and relatives’ covariates,
pix = f(Yij = 1|Yij′ = 1,Xij = x)f(Yij′ = 1) + f(Yij = 1|Yij′ = 0,Xij = x)f(Yij′ = 0),
follows from (B.1). We can rewrite the preceding equation as
pix = pix
A
pi + pix
U
(1− pi), (B.2)
where pix
A
≡ f(Yij = 1|Yij′ = 1,Xij = x) and pixU ≡ f(Yij = 1|Yij′ = 0,Xij = x). The
parameters pix
A
and pix
U
can be defined in terms of the finite population:
pix
A
=
∑F
i=1
∑Ni
j=1 I(Yij = 1)I(Xij = x)
∑
j′ 6=j I(Yij′ = 1)∑F
i=1
∑Ni
j=1 I(Xij = x)
∑
j′ 6=j I(Yij′ = 1)
=
∑F
i=1
∑Ni
j=1 I(Yij = 1)I(Xij = x)(NAi − 1)∑F
i=1
∑Ni
j=1
(
I(Xij = x)I(Yij = 1)(NAi − 1) + I(Xij = x)I(Yij = 0)NAi
)
=
∑F
i=1 N
Ax
i (N
A
i − 1)∑F
i=1
(
Nxi N
A
i −NAxi
) , (B.3)
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and
pix
U
=
∑F
i=1
∑Ni
j=1 I(Yij = 1)I(Xij = x)
∑
j′ 6=j I(Yij′ = 0)∑F
i=1
∑Ni
j=1 I(Xij = x)
∑
j′ 6=j I(Yij′ = 0)
=
∑F
i=1
∑Ni
j=1 I(Yij = 1)I(Xij = x)NUi∑F
i=1
∑Ni
j=1
(
I(Xij = x)I(Yij = 1)NUi + I(Xij = x)I(Yij = 0)(NUi − 1)
)
=
∑F
i=1 N
Ax
i N
U
i∑F
i=1
(
Nxi N
U
i −NUxi
) (B.4)
where NAi =
∑Ni
j=1 I(Yij = 1); NUi =
∑Ni
j=1 I(Yij = 0); Nxi =
∑Ni
j=1 I(Xij = x);
NAxi =
∑Ni
j=1 I(Yij = 1)I(Xij = x); and NUxi =
∑Ni
j=1 I(Yij = 0)I(Xij = x).
Now, recall that
pˆix = px
A
pˆi + px
U
(1− pˆi), (B.5)
where
px
A
=
F
A∑
i˜=1
ni∑˜
j˜=2
I(Xi˜j˜= x)I(Yi˜j˜= 1)
F
A∑
i˜=1
ni∑˜
j˜=2
I(Xi˜j˜= x)
and
px
U
=
F
A
+F
U∑
i˜=FA+1
ni∑˜
i˜=2
I(Xi˜j˜= x)I(Yi˜j˜= 1)
F
A
+F
U∑
i˜=FA+1
ni∑˜
i˜=2
I(Xi˜j˜= x)
.
The estimator pˆix in (B.5) can be approximated by a second-order Taylor expansion around
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Epˆi, Epx
U
and Epx
A
:
pˆix ≈ (Epx
A
Epˆi + Epx
U
(1− Epˆi))
+(pˆi − Epˆi) ∂pˆi
x
∂pˆi
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+
(
px
U
− Epx
U
) ∂pˆix
∂px
U
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+
(
px
A
− Epx
A
) ∂pˆix
∂px
A
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+
1
2
(pˆi − Epˆi)2 ∂
2pˆix
∂pˆi2
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+
1
2
(
px
U
− Epx
U
)2 ∂2pˆix
∂px
U
2
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+
1
2
(
px
A
− Epx
A
)2 ∂2pˆix
∂px
A
2
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+(pˆi − Epˆi) (px
A
− Epx
A
) ∂2pˆix
∂pˆi∂px
A
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+ (pˆi − Epˆi) (px
U
− Epx
U
) ∂2pˆix
∂pˆi∂px
U
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+
(
px
U
− Epx
U
) (
px
A
− Epx
A
) ∂2pix
∂px
U
∂px
A
∣∣∣∣
Epˆi,Epx
U
,Epx
A
.
Taking the expectation of both sides of the above equation yields
Epˆix ≈ (Epx
A
Epˆi + Epx
U
(1− Epˆi)) (B.6)
+
1
2
Var(pˆi)
∂2pˆix
∂pˆi2
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+
1
2
Var(px
U
)
∂2pˆix
∂px
U
2
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+
1
2
Var(px
A
)
∂2pˆix
∂px
A
2
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+ Cov(pˆi, px
A
)
∂2pˆix
∂pˆi∂px
A
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+ Cov(pˆi, px
U
)
∂2pˆix
∂pˆi∂px
U
∣∣∣∣
Epˆi,Epx
U
,Epx
A
+ Cov(px
U
, px
A
)
∂2pix
∂px
U
∂px
A
∣∣∣∣
Epˆi,Epx
U
,Epx
A
.
We focus now on the leading term of the expectation of the Taylor expansion in (B.6): Epx
A
Epˆi+
Epx
U
(1 − Epˆi). We have already shown in Appendix A that, under conditions (i.)-(v.), pˆi has a
very small negative bias as an estimator for pi. To derive the bias in px
A
and px
U
, we introduce
indicators in order to rewrite them as
px
A
=
F∑
i=1
∑
{j: j∈J˜i}
δAxij I(Xij = x)I(Yij = 1) +
F∑
i=1
∑
{j: j∈J˜i}
δAx
c
ij I(Xij = x)I(Yij = 1)
F∑
i=1
∑
{j: j∈J˜i}
δAxij I(Xij = x) +
F∑
i=1
∑
{j: j∈J˜i}
δAx
c
ij I(Xij = x)
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where δAxij (or δAx
c
ij ) equals 1 if family member ij is sampled as part of a family ascertained
through a case proband with covariate value x (or covariate value in the complement of x) and
equals 0 otherwise; and
px
U
=
F∑
i=1
∑
{j: j∈J˜i}
δUxij I(Xij = x)I(Yij = 1) +
F∑
i=1
∑
{j: j∈J˜i}
δUx
c
ij I(Xij = x)I(Yij = 1)
F∑
i=1
∑
{j: j∈J˜i}
δUxij I(Xij = x) +
F∑
i=1
∑
{j: j∈J˜i}
δUx
c
ij I(Xij = x)
where δUxij (or δUx
c
ij ) equals 1 if family member ij is sampled as part of a family ascertained
through a control proband with covariate value x (or covariate value in the complement of x)
and equals 0 otherwise. For the sake of brevity, we will refer to the denominators of px
A
and px
U
as dx
A
and dx
U
, respectively.
To derive the bias of px
A
as an estimator for pix
A
, we use the same Hartley-Ross (1954)
approach employed for p
A
in Appendix A:
Cov
(
px
A
, dx
A
)
= E
( F∑
i=1
∑
{j: j∈J˜i}
δAxij I(Xij = x)I(Yij = 1) +
F∑
i=1
∑
{j: j∈J˜i}
δAx
c
ij I(Xij = x)I(Yij = 1)
)
− Epx
A
· E
( F∑
i=1
∑
{j: j∈J˜i}
δAxij I(Xij = x) +
F∑
i=1
∑
{j: j∈J˜i}
δAx
c
ij I(Xij = x)
)
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=
[ F∑
i=1
∑
{j: j∈J˜i}
E
(
E
(
δAxij |δAxi
))
I(Xij = x)I(Yij = 1)
+
F∑
i=1
∑
{j: j∈J˜i}
E
(
E
(
δAx
c
ij |δAx
c
i
))
I(Xij = x)I(Yij = 1)
]
− Epx
A
·
[ F∑
i=1
∑
{j: j∈J˜i}
E
(
E
(
δAxij |δAxi
))
I(Xij = x) +
F∑
i=1
∑
{j: j∈J˜i}
E
(
E
(
δAx
c
ij |δAx
c
i
))
I(Xij = x)
]
where δAxi equals 1 if family i is ascertained via an affected proband with covariate value x
and 0 otherwise, and where δAxci equals 1 if family i is ascertained via an affected proband
with covariate value in the complement of x and 0 otherwise. Invoking Assumption (v.), the
preceding line reduces to
Cov(px
A
, dx
A
) =
[
s
F∑
i=1
∑
{j: j∈J˜i}
E(δAxi )I(Xij = x)I(Yij = 1) + s
F∑
i=1
∑
{j: j∈J˜i}
E(δAx
c
i )I(Xij = x)I(Yij = 1)
]
− Epx
A
·
[
s
F∑
i=1
∑
{j: j∈J˜i}
E(δAxi )I(Xij = x) + s
F∑
i=1
∑
{j: j∈J˜i}
E(δAx
c
i )I(Xij = x)
]
=
[
s
F∑
i=1
E(δAxi )(NAxi − 1) + s
F∑
i=1
E(δAx
c
i )N
Ax
i
]
− Epx
A
·
[
s
F∑
i=1
E(δAxi )(Nxi − 1) + s
F∑
i=1
E(δAx
c
i )N
x
i
]
=
[
sF
A
s
A
F∑
i=1
NAxi (N
Ax
i − 1) + sFA sA
F∑
i=1
NAx
c
i N
Ax
i
]
− Epx
A
·
[
sF
A
s
A
F∑
i=1
NAxi (N
x
i − 1) + sFA sA
F∑
i=1
NAx
c
i N
x
i
]
where NAxci =
∑Ni
j=1 I(Xij 6= x)I(Yij = 1). Note that the last expression above follows from
the second-to-last expression above under Assumption (iii.) about proband selection and As-
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sumption (iv.) about single ascertainment. The last expression above can be rewritten as
Cov(px
A
, d
A
) = sF
A
s
A
F∑
i=1
NAxi (N
A
i − 1)− EpxA · sFA sA
F∑
i=1
(
NAi N
x
i −NAxi
)
,
which, when rearranged and combined with (B.3), gives
Epx
A
− pix
A
= − Cov(p
x
A
, dx
A
)
sF
A
s
A
F∑
i=1
(
NAi N
x
i −NAxi
)
= − Cor(px
A
, dx
A
) · SD(px
A
) · CV(dx
A
). (B.7)
We can use the Hartley-Ross (1954) approach to obtain an analogous expression for the bias
of px
U
as an estimator for pix
U
:
Epx
U
− pix
U
= − Cov(p
x
U
, dx
U
)
sF
U
s
U
F∑
i=1
(
NUi N
x
i −NUxi
)
= − Cor(px
U
, dx
U
) · SD(px
U
) · CV(dx
U
). (B.8)
We can then use the same arguments made in Appendix A to establish that the right-hand
sides of (B.7) and (B.8) will be negligible when Assumption (ii.) holds. Thus, under Assump-
tion (ii.), px
A
and px
U
are approximately unbiased estimators for pix
A
and pix
U
, respectively. Using
our previous finding that pˆi slightly underestimate pi, along with the fact that px
A
will typically
exceed px
U
for diseases that aggregate in families, we see that the leading term in (B.6) under-
estimates pix slightly. Thus, to a first-degree approximation, pˆix is a slightly downwardly biased
estimator for pix. However, the results of the simulation experiment in Section 3 suggest that
the bias introduced by the leading term and also the higher order terms in (B.6) is very small. 
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APPENDIX C
Standard Errors and Confidence Intervals for pˆi and pˆix
The delta method can be used to obtain approximate standard errors for pˆi and pˆix. The approx-
imate standard error for pˆi is
se(pˆi) = pi(1− pi) (C.1)
·
√√√√√ piA
d
A
(1− pi
A
)

1 + 2ρA
d
A
F
A∑
i˜=1
(
ni˜− 12
)+ (1− piU )
d
U
pi
U

1 + 2ρU
d
U
F
A
+F
U∑
i˜=FA+1
(
ni˜− 12
),
where d
A
=
∑F
A
i˜=1
∑ni˜j˜=2 1 and dU =
∑F
A
+F
U
i˜=FA+1
∑ni˜j˜=2 1; ρA = Cor(Yi˜j˜, Yi˜j˜′) for i˜= 1, . . . , FA ,
j˜ > 1, j˜′ > 1, and j˜ 6= j˜′; and ρU = Cor(Yi˜j˜, Yi˜j˜′) for i˜= FA +1, . . . , FA +FU , j˜ > 1, j˜′ > 1,
and j˜ 6= j˜′. Note that the more the disease aggregates in families, the larger ρA and ρU will be
and therefore the larger the standard error for pˆi will be.
The approximate standard error for pˆix is
se(pˆix) =
√
aΣa
T
, (C.2)
where
a =
[
pi (1− pi) (pi
x
A
−pix
U
)pi2
pi
U
(pix
A
−pix
U
)(1−pi)2
1−pi
A
]
; (C.2.a)
and
Σ =


σ1,1 0 σ1,3 0
0 σ2,2 0 σ2,4
σ1,3 0 σ3,3 0
0 σ2,4 0 σ4,4


(C.2.b)
with
σ1,1 =
pix
A
(1− pix
A
)
dx
A

1 + 2ρxA
dx
A
F
A∑
i˜=1
(
nxi
2˜
) ,
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σ2,2 =
pix
U
(1− pix
U
)
dx
U

1 + 2ρxU
dx
U
F
A
+F
U∑
i˜=FA+1
(
nxi
2˜
) ,
σ3,3 =
pi
A
(1− pi
A
)
d
A

1 + 2ρA
d
A
F
A∑
i˜=1
(
ni˜− 12
) ,
σ4,4 =
pi
U
(1− pi
U
)
d
U

1 + 2ρU
d
U
F
A
+F
U∑
i˜=FA+1
(
ni˜− 12
) ,
σ1,3 =
1
dx
A
d
A

σ1,1 + ρx,xc
A
F
A∑
i˜=1
nxi˜nx
c
i˜

 ,
and
σ2,4 =
1
dx
U
d
U

σ2,2 + ρx,xc
U
F
A
+F
U∑
i˜=FA+1
nxi˜nx
c
i˜


.
Further, dx
A
=
∑F
A
i˜=1
∑ni˜j˜=2 I(Xi˜j˜= x) and d
x
U
=
∑F
A
+F
U
i˜=FA+1
∑ni˜j˜=2 I(Xi˜j˜= x);
nxi˜ =
∑ni˜j˜=2 I(Xi˜j˜= x) and n
xc
i˜ =
∑ni˜j˜=2 I(Xi˜j˜ 6= x); ρ
x
A
= Cor(Yi˜j˜, Yi˜j˜′) for i˜= 1, . . . , FA ,
j˜ > 1, j˜′ > 1, j˜ 6= j˜′, Xi˜j˜ = Xi˜j˜′ = x; ρxU = Cor(Yi˜j˜, Yi˜j˜′) for i˜ = FA + 1, . . . , FA + FU ,
j˜ > 1, j˜′ > 1, j˜ 6= j˜′, Xi˜j˜= Xi˜j˜′ = x; ρx,x
c
A
= Cor(Yi˜j˜, Yi˜j˜′) for i˜= 1, . . . , FA , j˜ > 1, j˜′ > 1,
j˜ 6= j˜′, Xi˜j˜= x, Xi˜j˜′ 6= x; and ρx,x
c
U
= Cor(Yi˜j˜, Yi˜j˜′) for i˜= FA +1, . . . , FA + FU , j˜, j˜′ > 1,
j˜ 6= j˜′, Xi˜j˜= x, Xi˜j˜′ 6= x.
In practice, the population parameters in Equations (C.1) and (C.2) are replaced with esti-
mates, which yields estimated standard errors that we refer to as sˆe(pˆi) and sˆe(pˆix), respectively.
Although estimating the parameters pi, pi
A
, pi
U
, pix
A
, and pix
U
will not require additional calcula-
tion because they appear in Equations (2.1) and (2.2), the parameters ρ
A
, ρ
U
, ρx
A
, ρx
U
, ρx,x
c
A
, and
ρx,x
c
U
will need to be calculated from the data using Pearson correlations.
The estimated quantities pˆi and sˆe(pˆi) could be used to form a Wald interval for pi, which
would take the form CI = [pˆi ± zα/2sˆe(pˆi)], where zα/2 is the α/2 quantile of the standard nor-
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mal distribution. However, for small population prevalences (pi < 0.2), Wald intervals do not
achieve their nominal coverage level because of the frequent occurrence of [0, 0] intervals for
samples with no diseased relatives. Various adjusted confidence intervals with improved cov-
erage probabilities have been proposed for population proportions, including the Agresti-Coull
(1998) interval, which has its roots in the work of Wilson (1927). Simply put, the Agresti-Coull
interval improves the Wald interval’s coverage properties by smoothing the proportion estimates
and the estimated standard errors away from zero. Miao and Gastwirth (2004) have performed
simulations to examine the performance of an Agresti-Coull-type interval (and various other
intervals) for proportions estimated from moderately-sized samples containing dependent clus-
ters. Since the Agresti-Coull-type interval appears to perform well in the simulations and,
further, is easy to compute, we adopt confidence intervals based on the same concept.
For the overall prevalence, the 100 · (1− α)% interval takes the form:
CI = pi ± zα/2
√
s˜e (C.3)
where pi and s˜e are calculated using the formulas for pˆi and sˆe(pˆi), respectively, with p
A
replaced
by
p˜
A
=
d
A
p
A
+ (0.5z2α/2)/100
d
A
+ (z2α/2)/100
and p
U
replaced by
p˜
U
=
d
U
p
U
+ (0.5z2α/2)/100
d
U
+ (z2
α/2
)/100
.
For the stratum-specific prevalence, pix, the 100 · (1− α)% interval takes the form:
CI = pix ± zα/2
√
s˜ex (C.4)
where pix and s˜ex are calculated using the formulas for pˆix and sˆe(pˆix), respectively, with p
A
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replaced by p˜
A
, p
U
replaced by p˜
U
, px
A
replaced by
p˜x
A
=
dx
A
px
A
+ (0.5z2α/2)/100
dx
A
+ (z2α/2)/100
and px
U
replaced by
p˜x
U
=
dx
U
px
U
+ (0.5z2α/2)/100
dx
U
+ (z2α/2)/100
.
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Table 1: Number of Relatives With (Without) Major Depressive Disorder∗
Proband Sex of Relatives
Disease Status Male Female
Case 8 (65) 25 (80)
Control 4 (69) 8 (71)
∗ MDD was diagnosed by interviewing probands and their relatives using
the German translation (Wittchen et al. 1996) of the Structured Clinical
Interview for DSM-IV (First et al. 1994).
Table 2: Components of the Bias of p
A
When Assumption (ii.) Does and Does Not Hold
Term Value
(for F
A
= 64 and s = 1)
Population 1 Population 2
Cor(Ni, N
A
i
Ni
) ≈ 0 Cor(Ni, N
A
i
Ni
) ≈ −0.19
Cor
(
p
A
,
∑F
i=1
∑
{j: j∈J˜i} δAij
)
0.001459 -0.137009
SD(p
A
) 0.033318 0.038691
CV(
∑F
i=1
∑
{j: j∈J˜i} δAij) 0.058140 0.054310
Percentage bias of p
A
†
-0.0017% 0.173%
† Percentage bias of p
A
equals 100 ·
(
Ep
A
−pi
A
pi
A
)
, where pi
A
≈ 0.16; and where
Ep
A
− pi
A
= Cor
(
p
A
,
F∑
i=1
∑
{j: j∈J˜i}
δAij
)
· SD(p
A
) · CV( F∑
i=1
∑
{j: j∈J˜i}
δAij
)
.
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Table 3: Components of the Bias of p
U
When Assumption (ii.) Does and Does Not Hold
Term Value
(for F
U
= 58 and s = 1)
Population 1 Population 2
Cor(Ni, N
A
i
Ni
) ≈ 0 Cor(Ni, N
A
i
Ni
) ≈ −0.19
Cor
(
p
U
,
∑F
i=1
∑
{j: j∈J˜i} δUij
)
-0.008865 -0.098235
SD(p
U
) 0.025768 0.020937
CV(
∑F
i=1
∑
{j: j∈J˜i} δUij) 0.061170 0.060793
Percentage bias of p
U
† 0.0018% 0.2281%
† Percentage bias of p
U
equals 100 ·
(
Ep
U
−pi
U
pi
U
)
, where pi
U
≈ 0.055; and where
Ep
U
− pi
U
= Cor
(
p
U
,
F∑
i=1
∑
{j: j∈J˜i}
δUij
)
· SD(p
U
) · CV( F∑
i=1
∑
{j: j∈J˜i}
δUij
)
.
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Figure 1. Boxplots of overall, male, and female prevalence estimates from 1, 000 small case-
control family datasets with 64 case probands and 58 control probands. Xs indicate the corre-
sponding population prevalences.
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